July 12th, 2010 by AndrewSchorr in Better Health Network, Health Policy, News, Opinion, Research
No Comments »
They have a tough job, those government doctors, scientists, and bureaucrats who are charged with assessing the safety and effectiveness of proposed new medical products. As you know, they rely largely on studies presented by the applicants.
The Food and Drug Administration (FDA) has the power to not approve a new drug or product or even pull it off the market. Right now it is considering limiting or pulling GlaxoSmithKline’s (GSK) diabetes drug, Avandia, because of newly discovered data that it may have caused heart attack in some patients –- data mysteriously not shown in GSK’s own studies. If the drug is pulled it will cost GSK billions of dollars in lost revenue but, from the FDA’s point-of-view, it will be protecting the public. And, after all, there are safer diabetes drugs on the market as alternatives. Read more »
*This blog post was originally published at Andrew's Blog*
July 12th, 2010 by GarySchwitzer in Better Health Network, Health Policy, News, Opinion
No Comments »
Kaiser Health News proves its value once again with an under-the-radar story covering some items you won’t see in many other news sources. An excerpt:
“…several lesser-known provisions also take effect in coming months that could have a lasting impact on the nation’s health care system.
These provisions include eliminating patients’ co-payments for certain preventive services such as mammograms, giving the government more power to review health insurers’ premium increases and allowing states to expand Medicaid coverage to low-income adults without children.
While these changes might not have gotten at lot of attention, they could help build support for the law in the run-up to the contentious mid-term elections.”
Their list:
• Prevention For Less
• Knowing Which Treatments Work Best
• Helping Cover Early Retirees’ Health Costs
• Keeping Tabs on Health Insurance Premiums
• Expanded Medicaid Coverage
• Care Coordination for ‘Dual Eligibles’
• FDA Approval For ‘Follow-On Biologics’
Read the full story at the link above for details.
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
July 12th, 2010 by KevinMD in Better Health Network, Health Policy, News, Opinion, Research
No Comments »
How effective is direct-to-consumer drug advertising? Some think that drug ads should be banned altogether, saying that it encourages patients to ask their doctors for expensive, brand name prescription drugs. It turns out their fears may be overblown.
NPR’s Shots blogs about a recent study looking at the effectiveness of these ads. The numbers, for the pharmaceutical companies anyways, are not encouraging. Read more »
*This blog post was originally published at KevinMD.com*
July 11th, 2010 by DrRob in Better Health Network, Humor, Opinion, True Stories
No Comments »
I just got back from extended time off, which brings to mind a post I wrote two years ago:
Here’s an observation: most physicians in private practice don’t take enough vacations. I am often (rightly) accused of this sin. My staff, colleagues, and even patients regularly encourage me to take time off, but still I find it hard.
Why is this? Is it that I love my job so much that I can’t tear myself away from it? Is it that my self-worth is wrapped up in being “the man” for my patients, and being away from this makes me feel insecure? Is work my addiction –- the one place that I have control of my circumstances and positive reinforcement? Perhaps. But I think the reasons are more basic than that. Read more »
*This blog post was originally published at Musings of a Distractible Mind*
July 11th, 2010 by Bryan Vartabedian, M.D. in Better Health Network, Humor, Opinion, True Stories
No Comments »
They say transparency is king — the more you share the better you look. But I’ve got rules. Here are a few things you won’t find in my Twitter stream:
Beer. I was recently speaking at a meeting out of town and caught up with some friends at the end of the day to visit and have a beer. I was in a different time zone and noted on Twitter the specific microbrew I was enjoying. The following week in my clinic a parent commented on my social activity. While I’m no stranger to transparency, the realization of my visibility was eye-opening. It reminded me that everyone’s watching and 140 characters doesn’t offer enough space to explain the why, or the time zone, of what I’m doing. So I’ve sworn to keep activities like beer consumption out of my twitter stream.
My kids. I try to keep my children out of my social footprint as much as possible. But as most of you who follow me know, they sneak their cute little selves in on occasion. It’s unfortunate because everybody loves hearing about my kids. This is at the request of my wife who’s a booger about privacy. I do mention the occasional date night with my daughter but, by and large, you won’t hear much. Kids are great jumping-off points for personal digression, but we have to be careful about using them to our own advantage. Read more »
*This blog post was originally published at 33 Charts*
